Navigation Links
ABI Testing Kit

ProductsABI Testing Kit
Company Nicolet Vascular
Item ABI Testing Kit
Features 
  • Nicolet Elite 100*, a reliable, highly-sensitive Doppler (a PocketDop II or StethoDop can be substituted with a price adjustment)
  • either a 5 MHz or 8 MHz probe
  • a selection of four quick disconnect vascular cuffs
  • sphygmomanometer
  • training CD
  • ABI chart
  • reference guide
  • report forms and vascular history questionnaire
  • 30-Day FREE Trial
  • Description To aid clinicians in performing Ankle/Brachial Index (ABI) testing, Nicolet Vascular has developed a new, complete packet of information. It includes a 10-minute compact disk ABI training presentation that can be viewed on any computer with a CD drive. It shows the step-by-step procedure of performing an ABI test, provides information on the materials that are needed, and indicates who is an appropriate candidate for the test. Also included in the packet is a quick-reference booklet of the CD presentation, a patient information brochure, and a report form and vascular history questionnaire with an ABI chart. Physicians find this information packet very useful for their own education, and the education of their staff and patients.
    Info Nicolet Vascular
    Customer Service: (800) 356-0007
    Web site: http://www.viasyshealthcare.com/

    Related medicine products :

    1. D-10 Hemoglobin Testing System with D-10™ Rack Loader
    2. Hgb Pro Professional Hemoglobin Testing System
    3. StressVue Exercise Stress Testing System
    4. Point Of Care Testing (POCT) Information System
    5. AAFP-PT Laboratory Proficiency Testing and Quality Assurance
    6. Clinical Proficiency Testing Programs
    7. VARIANT II TURBO Hemoglobin Testing System
    8. Sidekick™ Blood Glucose Testing System
    9. pH Testing - Advanced Analysis
    10. Anorectal Function Testing
    11. Standard pH Testing Application
    Breaking Medicine Technology:Dynatronics Receives 180-Day NASDAQ Extension 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 2Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 3Relapse of Infections is the Most Challenging Aspect of Treating Clostridium Difficile Infections in the Hospital Setting 55979 1Relapse of Infections is the Most Challenging Aspect of Treating Clostridium Difficile Infections in the Hospital Setting 55979 2Relapse of Infections is the Most Challenging Aspect of Treating Clostridium Difficile Infections in the Hospital Setting 55979 3Jiangbo Pharmaceuticals to Present at Rodman 26 Renshaw Annual Global Investment Conference 13788 1Jiangbo Pharmaceuticals to Present at Rodman 26 Renshaw Annual Global Investment Conference 13788 2Jiangbo Pharmaceuticals to Present at Rodman 26 Renshaw Annual Global Investment Conference 13788 3September 2009 is Atrial Fibrillation Month 55975 1September 2009 is Atrial Fibrillation Month 55975 2